CETIIRIZINE

CETIIRIZINE was reported 43264 times

These side effects are most commonly reported by patients taking CETIIRIZINE:

# Side effect Count
0 FATIGUE 5851
1 DRUG INEFFECTIVE 5321
2 PAIN 5156
3 RASH 5123
4 OFF LABEL USE 4629
5 DYSPNOEA 4627
6 PRURITUS 4541
7 ARTHRALGIA 4078
8 PYREXIA 3959
9 HYPERSENSITIVITY 3788
10 HEADACHE 3706
11 NAUSEA 3699
12 JOINT SWELLING 3614
13 SWELLING 3606
14 ABDOMINAL DISCOMFORT 3549
15 DIARRHOEA 3493
16 PERIPHERAL SWELLING 3372
17 URTICARIA 3353
18 ALOPECIA 3340
19 INFUSION RELATED REACTION 3283
20 VOMITING 3273
21 RHEUMATOID ARTHRITIS 3237
22 WEIGHT INCREASED 3190
23 SYSTEMIC LUPUS ERYTHEMATOSUS 3129
24 NASOPHARYNGITIS 3111
25 CONFUSIONAL STATE 3075
26 PEMPHIGUS 2993
27 LOWER RESPIRATORY TRACT INFECTION 2977
28 HEPATIC ENZYME INCREASED 2974
29 INFECTION 2974
30 STOMATITIS 2950
31 BLISTER 2946
32 GLOSSODYNIA 2933
33 SINUSITIS 2913
34 PERICARDITIS 2887
35 SYNOVITIS 2792
36 FOLLICULITIS 2786
37 IMPAIRED HEALING 2784
38 HAND DEFORMITY 2771
39 IRRITABLE BOWEL SYNDROME 2752
40 ARTHROPATHY 2748
41 MALAISE 2724
42 WOUND 2699
43 DUODENAL ULCER PERFORATION 2688
44 DIZZINESS 2652
45 DRUG INTOLERANCE 2640
46 CONDITION AGGRAVATED 2609
47 HELICOBACTER INFECTION 2599
48 MUSCLE INJURY 2531
49 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 2442
50 GASTROINTESTINAL DISORDER 2418
51 DISCOMFORT 2385
52 HYPERTENSION 2379
53 INSOMNIA 2349
54 CONTRAINDICATED PRODUCT ADMINISTERED 2316
55 MATERNAL EXPOSURE DURING PREGNANCY 2293
56 ASTHENIA 2273
57 ILL-DEFINED DISORDER 2260
58 ABDOMINAL PAIN UPPER 2219
59 CONTUSION 2203
60 THERAPEUTIC PRODUCT EFFECT DECREASED 2182
61 GENERAL PHYSICAL HEALTH DETERIORATION 2178
62 WHEEZING 2052
63 PNEUMONIA 1996
64 DRUG HYPERSENSITIVITY 1985
65 SLEEP DISORDER 1940
66 ASTHMA 1886
67 HYPOAESTHESIA 1871
68 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 1859
69 TYPE 2 DIABETES MELLITUS 1829
70 ANXIETY 1820
71 PSORIATIC ARTHROPATHY 1725
72 PRODUCT USE ISSUE 1719
73 MOBILITY DECREASED 1688
74 INJURY 1687
75 FIBROMYALGIA 1660
76 DRY MOUTH 1628
77 DEPRESSION 1623
78 TREATMENT FAILURE 1622
79 PAIN IN EXTREMITY 1586
80 INTENTIONAL PRODUCT USE ISSUE 1585
81 PRODUCT USE IN UNAPPROVED INDICATION 1571
82 DECREASED APPETITE 1570
83 CHEST PAIN 1547
84 MUSCULOSKELETAL STIFFNESS 1533
85 ABDOMINAL PAIN 1509
86 RHEUMATIC FEVER 1464
87 BLOOD CHOLESTEROL INCREASED 1440
88 PARAESTHESIA 1411
89 MUSCLE SPASMS 1403
90 MEMORY IMPAIRMENT 1344
91 WEIGHT DECREASED 1316
92 MIGRAINE 1315
93 RHEUMATOID FACTOR POSITIVE 1315
94 JOINT RANGE OF MOTION DECREASED 1306
95 LIVER INJURY 1279
96 NIGHT SWEATS 1256
97 INFLAMMATION 1253
98 OSTEOARTHRITIS 1251
99 BURSITIS 1224
100 COUGH 1210
101 BACK PAIN 1209
102 MUSCULAR WEAKNESS 1196
103 OEDEMA 1184
104 DYSPEPSIA 1151
105 FACET JOINT SYNDROME 1137
106 LUNG DISORDER 1133
107 EXPOSURE DURING PREGNANCY 1110
108 GAIT INABILITY 1109
109 LIP DRY 1087
110 GAIT DISTURBANCE 1082
111 SWOLLEN JOINT COUNT INCREASED 1082
112 FALL 1058
113 ERYTHEMA 1045
114 MUSCULOSKELETAL PAIN 1043
115 C-REACTIVE PROTEIN ABNORMAL 1033
116 WOUND INFECTION 1008
117 CONSTIPATION 1007
118 OBESITY 1001
119 OEDEMA PERIPHERAL 937
120 BREAST CANCER STAGE III 891
121 ROAD TRAFFIC ACCIDENT 891
122 PRESCRIBED OVERDOSE 885
123 DEATH 868
124 HYPERHIDROSIS 866
125 AMNESIA 854
126 C-REACTIVE PROTEIN INCREASED 822
127 PERIPHERAL VENOUS DISEASE 822
128 LIVER DISORDER 812
129 ANGIOEDEMA 803
130 PRODUCT DOSE OMISSION ISSUE 802
131 GASTROOESOPHAGEAL REFLUX DISEASE 792
132 PSORIASIS 788
133 COVID-19 779
134 HYPERCHOLESTEROLAEMIA 774
135 LIVE BIRTH 770
136 THERAPY NON-RESPONDER 756
137 SOMNOLENCE 755
138 SCIATICA 749
139 EPILEPSY 741
140 ACUTE KIDNEY INJURY 737
141 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 733
142 AUTOIMMUNE DISORDER 731
143 GRIP STRENGTH DECREASED 724
144 TACHYCARDIA 719
145 LOWER LIMB FRACTURE 715
146 DEEP VEIN THROMBOSIS POSTOPERATIVE 710
147 OVERDOSE 709
148 INTENTIONAL PRODUCT MISUSE 699
149 PULMONARY FIBROSIS 697
150 DRUG INTERACTION 694
151 VISUAL IMPAIRMENT 686
152 UPPER RESPIRATORY TRACT INFECTION 672
153 HYPOTENSION 665
154 ADVERSE EVENT 659
155 DELIRIUM 650
156 FEELING ABNORMAL 647
157 MEDICATION ERROR 626
158 ADVERSE DRUG REACTION 617
159 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 616
160 CHEST DISCOMFORT 584
161 PALPITATIONS 579
162 THROMBOCYTOPENIA 578
163 KNEE ARTHROPLASTY 568
164 BLEPHAROSPASM 566
165 TASTE DISORDER 563
166 RESPIRATORY DISORDER 552
167 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 550
168 PRODUCT QUALITY ISSUE 547
169 BLOOD PRESSURE INCREASED 542
170 DRUG-INDUCED LIVER INJURY 538
171 HEART RATE INCREASED 538
172 LIP SWELLING 536
173 TOXICITY TO VARIOUS AGENTS 536
174 URINARY TRACT INFECTION 536
175 DISLOCATION OF VERTEBRA 531
176 ARTHRITIS 529
177 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 527
178 NECK PAIN 523
179 EAR PAIN 517
180 OSTEOPOROSIS 515
181 ANAPHYLACTIC REACTION 514
182 ANAEMIA 509
183 FEELING HOT 503
184 HIP ARTHROPLASTY 496
185 HOSPITALISATION 489
186 MYALGIA 489
187 ABDOMINAL DISTENSION 488
188 SWELLING FACE 488
189 LIVER FUNCTION TEST INCREASED 481
190 PREGNANCY 481
191 RASH ERYTHEMATOUS 467
192 CHRONIC KIDNEY DISEASE 465
193 FLUID RETENTION 465
194 COELIAC DISEASE 463
195 DEHYDRATION 456
196 TREMOR 452
197 CROHN^S DISEASE 447
198 NAIL DISORDER 439
199 EAR INFECTION 431
200 DRUG ABUSE 423
201 FEBRILE NEUTROPENIA 422
202 EXOSTOSIS 416
203 IMMUNODEFICIENCY 416
204 COLITIS ULCERATIVE 413
205 SEIZURE 410
206 RECTAL HAEMORRHAGE 408
207 FOETAL EXPOSURE DURING PREGNANCY 405
208 HALLUCINATION 405
209 ONYCHOMADESIS 404
210 BACK INJURY 403
211 PRESCRIBED UNDERDOSE 402
212 LUPUS VULGARIS 401
213 LOSS OF CONSCIOUSNESS 396
214 DISTURBANCE IN ATTENTION 395
215 FREQUENT BOWEL MOVEMENTS 395
216 CHILLS 394
217 BRONCHITIS 392
218 DYSPHAGIA 388
219 INJECTION SITE REACTION 387
220 X-RAY ABNORMAL 387
221 INFLUENZA 379
222 RENAL FAILURE 379
223 C-REACTIVE PROTEIN 371
224 DRY SKIN 370
225 JOINT STIFFNESS 369
226 FOOD ALLERGY 368
227 OROPHARYNGEAL PAIN 367
228 LARYNGITIS 365
229 BODY TEMPERATURE INCREASED 361
230 ILLNESS 359
231 RED BLOOD CELL SEDIMENTATION RATE INCREASED 354
232 HEPATIC CIRRHOSIS 352
233 LUPUS-LIKE SYNDROME 348
234 HYPOKALAEMIA 345
235 INJECTION SITE PAIN 345
236 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 343
237 RASH PRURITIC 342
238 RETINITIS 340
239 NASAL CONGESTION 339
240 SYNCOPE 338
241 COGNITIVE DISORDER 336
242 FOOT DEFORMITY 335
243 BLOOD GLUCOSE INCREASED 328
244 BALANCE DISORDER 325
245 PRODUCTIVE COUGH 323
246 UNDERDOSE 318
247 INCORRECT DOSE ADMINISTERED 317
248 VISION BLURRED 317
249 BONE EROSION 316
250 DEPRESSED MOOD 310
251 SUICIDAL IDEATION 309
252 JOINT DISLOCATION 298
253 MUSCLE SPASTICITY 297
254 OXYGEN SATURATION DECREASED 296
255 MUSCLE TWITCHING 293
256 NEUTROPENIA 291
257 THERAPEUTIC RESPONSE DECREASED 287
258 FLUSHING 286
259 EMOTIONAL DISTRESS 283
260 EYE PRURITUS 282
261 NEUROPATHY PERIPHERAL 281
262 AGITATION 280
263 TINNITUS 280
264 WALKING AID USER 280
265 NO ADVERSE EVENT 277
266 WHITE BLOOD CELL COUNT INCREASED 277
267 MYOCARDIAL INFARCTION 274
268 MACULAR DEGENERATION 272
269 SWOLLEN TONGUE 272
270 MATERNAL EXPOSURE TIMING UNSPECIFIED 270
271 ECZEMA 269
272 DISABILITY 267
273 ONYCHOMYCOSIS 264
274 SEPSIS 262
275 RHINORRHOEA 257
276 BREAST CANCER STAGE II 256
277 STRESS 254
278 HYPONATRAEMIA 253
279 TEMPERATURE REGULATION DISORDER 253
280 ATRIAL FIBRILLATION 250
281 HEPATITIS 250
282 THROAT IRRITATION 249
283 WITHDRAWAL SYNDROME 242
284 HAEMATOCHEZIA 240
285 PANCREATITIS 238
286 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 236
287 BURNING SENSATION 235
288 VERTIGO 232
289 CONGENITAL ANOMALY 229
290 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 229
291 SKIN EXFOLIATION 226
292 COLITIS 222
293 PARAESTHESIA ORAL 222
294 TRANSIENT ISCHAEMIC ATTACK 217
295 HAEMOGLOBIN DECREASED 216
296 LETHARGY 215
297 INTENTIONAL OVERDOSE 214
298 ALANINE AMINOTRANSFERASE INCREASED 213
299 DISEASE PROGRESSION 211
300 FACIAL PAIN 209
301 FINGER DEFORMITY 208
302 EPISTAXIS 206
303 SUBARACHNOID HAEMORRHAGE 206
304 CARDIAC ARREST 205
305 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 203
306 DYSPHONIA 203
307 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 202
308 CYTOKINE RELEASE SYNDROME 200
309 MUCOSAL INFLAMMATION 199
310 RENAL IMPAIRMENT 199
311 SLEEP TERROR 199
312 PLATELET COUNT DECREASED 198
313 DIPLOPIA 196
314 BLOOD CREATININE INCREASED 195
315 OBSTRUCTIVE AIRWAYS DISORDER 195
316 COMPLETED SUICIDE 194
317 ADRENAL INSUFFICIENCY 193
318 AGGRESSION 193
319 HOT FLUSH 192
320 RESPIRATORY FAILURE 192
321 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 191
322 DERMATITIS ATOPIC 191
323 ANOSMIA 190
324 PORPHYRIA ACUTE 190
325 FOETAL DEATH 188
326 INFUSION SITE REACTION 188
327 PAIN OF SKIN 187
328 ULCER HAEMORRHAGE 187
329 WHITE BLOOD CELL COUNT DECREASED 187
330 BLINDNESS 186
331 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 182
332 DRY EYE 181
333 IRRITABILITY 181
334 MYOSITIS 181
335 PRURITUS GENITAL 178
336 PULMONARY EMBOLISM 177
337 BLOOD PRESSURE DECREASED 176
338 DISORIENTATION 176
339 DRUG TOLERANCE DECREASED 176
340 THERAPY INTERRUPTED 176
341 VASCULITIS 176
342 VENTRICULAR TACHYCARDIA 176
343 BRADYCARDIA 175
344 DYSPNOEA EXERTIONAL 175
345 ELECTROCARDIOGRAM QT PROLONGED 174
346 PROCEDURAL PAIN 173
347 RASH VESICULAR 173
348 LEUKOPENIA 171
349 CHRONIC SINUSITIS 170
350 LABORATORY TEST ABNORMAL 170
351 PLEURAL EFFUSION 170
352 RASH PAPULAR 170
353 THROAT TIGHTNESS 169
354 ASPARTATE AMINOTRANSFERASE INCREASED 167
355 DRUG DEPENDENCE 165
356 HAEMORRHAGE 165
357 ORAL CANDIDIASIS 165
358 APLASTIC ANAEMIA 164
359 CARDIAC FAILURE 164
360 BACK DISORDER 163
361 INJECTION SITE ERYTHEMA 163
362 CELLULITIS 161
363 PRODUCT LABEL CONFUSION 160
364 PUSTULAR PSORIASIS 160
365 JAUNDICE 159
366 DISEASE RECURRENCE 158
367 RASH MACULO-PAPULAR 158
368 NIGHTMARE 156
369 TENSION HEADACHE 156
370 CARDIOSPASM 154
371 ATRIAL TACHYCARDIA 153
372 RASH MACULAR 153
373 CATARACT 152
374 DYSGEUSIA 152
375 EYE SWELLING 152
376 CAROTID ARTERY OCCLUSION 151
377 RESPIRATORY TRACT INFECTION 150
378 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 150
379 EOSINOPHILIA 149
380 LACRIMATION INCREASED 149
381 PANCYTOPENIA 149
382 PALMOPLANTAR KERATODERMA 148
383 URINARY RETENTION 147
384 MIDDLE INSOMNIA 146
385 HYPERKALAEMIA 145
386 INFLUENZA LIKE ILLNESS 145
387 HYPOXIA 144
388 LYMPHADENOPATHY 144
389 SUICIDE ATTEMPT 143
390 DYSARTHRIA 141
391 DYSURIA 140
392 BONE PAIN 139
393 GENERAL SYMPTOM 139
394 CEREBROVASCULAR ACCIDENT 137
395 PROCTITIS 137
396 PRURITUS GENERALISED 136
397 VAGINAL DISCHARGE 135
398 EYE IRRITATION 134
399 ANHEDONIA 133
400 NEPHROLITHIASIS 133
401 GASTROINTESTINAL HAEMORRHAGE 132
402 INJECTION SITE SWELLING 132
403 NORMAL NEWBORN 132
404 SKIN LESION 132
405 DRUG TOLERANCE 131
406 SEASONAL ALLERGY 131
407 URINARY INCONTINENCE 131
408 COMA 128
409 ADVERSE REACTION 127
410 FLATULENCE 127
411 ANAPHYLACTIC SHOCK 126
412 SERONEGATIVE ARTHRITIS 126
413 CRYING 125
414 SEPTIC SHOCK 125
415 THERAPY CESSATION 125
416 VIRAL INFECTION 125
417 CARDIAC FAILURE CONGESTIVE 124
418 COORDINATION ABNORMAL 124
419 PANIC ATTACK 124
420 PRODUCT SUBSTITUTION ISSUE 124
421 RADICULOPATHY 124
422 WEIGHT FLUCTUATION 124
423 BLOOD PRESSURE FLUCTUATION 123
424 DRUG DOSE OMISSION 123
425 FEMALE GENITAL TRACT FISTULA 123
426 SKIN DISCOLOURATION 123
427 SPEECH DISORDER 123
428 THROMBOSIS 123
429 TREATMENT NONCOMPLIANCE 123
430 HYPOGLYCAEMIA 122
431 LIMB DISCOMFORT 122
432 DIABETES MELLITUS 121
433 ACCIDENTAL OVERDOSE 120
434 GASTROENTERITIS VIRAL 120
435 IMPAIRED QUALITY OF LIFE 120
436 PRESYNCOPE 120
437 ANGER 119
438 END STAGE RENAL DISEASE 119
439 THERAPEUTIC RESPONSE SHORTENED 119
440 BLOOD POTASSIUM DECREASED 118
441 PULMONARY PAIN 118
442 VAGINAL FLATULENCE 118
443 MYDRIASIS 117
444 RETCHING 116
445 POLYARTHRITIS 113
446 CARDIAC DISORDER 112
447 JOINT DESTRUCTION 111
448 MOUTH ULCERATION 111
449 RESTLESSNESS 111
450 APHASIA 110
451 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 109
452 PNEUMONITIS 109
453 SNEEZING 108
454 HEART RATE DECREASED 107
455 INJECTION SITE BRUISING 105
456 PRODUCT DOSE OMISSION IN ERROR 105
457 EYE DISORDER 104
458 SLEEP APNOEA SYNDROME 104
459 BLOOD PRESSURE SYSTOLIC INCREASED 103
460 EYE PAIN 103
461 HYPERGLYCAEMIA 103
462 SKIN BURNING SENSATION 103
463 MALIGNANT NEOPLASM PROGRESSION 102
464 ORAL PAIN 102
465 ARRHYTHMIA 101
466 INTENTIONAL SELF-INJURY 101
467 RED BLOOD CELL COUNT DECREASED 101
468 RHABDOMYOLYSIS 101
469 RHINITIS 101
470 UNEVALUABLE EVENT 101
471 DEEP VEIN THROMBOSIS 100
472 PHARYNGEAL SWELLING 100
473 DRUG WITHDRAWAL SYNDROME 99
474 GRIP STRENGTH 99
475 HERPES ZOSTER 99
476 NERVOUSNESS 99
477 STEVENS-JOHNSON SYNDROME 99
478 TOXIC EPIDERMAL NECROLYSIS 99
479 CHROMATURIA 98
480 CHRONIC SPONTANEOUS URTICARIA 97
481 INTENTIONAL DOSE OMISSION 97
482 OCULAR HYPERAEMIA 97
483 IMMUNISATION 96
484 PHOTOSENSITIVITY REACTION 95
485 CYSTITIS 94
486 DEMENTIA 94
487 FUNGAL INFECTION 94
488 GASTRITIS 94
489 PULMONARY OEDEMA 94
490 SWOLLEN JOINT COUNT 94
491 FEELING COLD 93
492 PRODUCT DOSE OMISSION 93
493 TOOTH FRACTURE 93
494 FORCED EXPIRATORY VOLUME DECREASED 92
495 SINUS DISORDER 92
496 DYSKINESIA 91
497 HAEMOPTYSIS 91
498 MOOD SWINGS 91
499 PANCREATITIS ACUTE 91
500 CARDIO-RESPIRATORY ARREST 90
501 HEPATOCELLULAR INJURY 90
502 IMPAIRED GASTRIC EMPTYING 90
503 RENAL DISORDER 90
504 SKIN PLAQUE 90
505 TUBULOINTERSTITIAL NEPHRITIS 90
506 BLOOD CALCIUM DECREASED 89
507 HEAD INJURY 89
508 MOOD ALTERED 89
509 OVERLAP SYNDROME 89
510 CONJUNCTIVITIS 88
511 INJECTION SITE PRURITUS 88
512 SPONDYLITIS 88
513 DEVICE ISSUE 87
514 FULL BLOOD COUNT ABNORMAL 87
515 MOVEMENT DISORDER 87
516 SEDATION 87
517 TYPE I HYPERSENSITIVITY 87
518 UNRESPONSIVE TO STIMULI 87
519 BONE DENSITY DECREASED 86
520 HYPERSOMNIA 86
521 RESPIRATORY DISTRESS 86
522 DRUG ERUPTION 85
523 PAIN IN JAW 85
524 SKIN REACTION 85
525 ABNORMAL BEHAVIOUR 84
526 ACUTE RESPIRATORY FAILURE 84
527 AGEUSIA 84
528 BLOOD ALKALINE PHOSPHATASE INCREASED 84
529 HYPOMAGNESAEMIA 84
530 SINUS CONGESTION 84
531 ULCER 84
532 ACNE 83
533 HYPOCALCAEMIA 83
534 MENTAL DISORDER 83
535 BLOOD UREA INCREASED 82
536 BRAIN FOG 82
537 POOR QUALITY SLEEP 82
538 HYPOTHYROIDISM 81
539 RENAL INJURY 81
540 SCRATCH 81
541 ACCIDENTAL EXPOSURE TO PRODUCT 80
542 DERMATITIS ALLERGIC 80
543 MULTIPLE SCLEROSIS 80
544 INCORRECT PRODUCT ADMINISTRATION DURATION 79
545 PRODUCT ADMINISTRATION ERROR 79
546 RESPIRATORY TRACT CONGESTION 79
547 BLOOD COUNT ABNORMAL 78
548 PALLOR 78
549 RESTLESS LEGS SYNDROME 78
550 TEMPERATURE INTOLERANCE 78
551 FACE OEDEMA 77
552 LIVER FUNCTION TEST ABNORMAL 77
553 PHOTOPHOBIA 77
554 POLLAKIURIA 77
555 BLOOD IMMUNOGLOBULIN E INCREASED 76
556 DEPRESSED LEVEL OF CONSCIOUSNESS 76
557 HYPOAESTHESIA ORAL 76
558 CIRCULATORY COLLAPSE 75
559 FLANK PAIN 75
560 PARKINSON^S DISEASE 75
561 PHARYNGITIS 75
562 POISONING 75
563 BREAST CANCER 74
564 GAMMA-GLUTAMYLTRANSFERASE INCREASED 74
565 HAEMATOMA 74
566 SECRETION DISCHARGE 74
567 CHOLELITHIASIS 73
568 MELAENA 73
569 PHARYNGEAL OEDEMA 73
570 VITAMIN D DEFICIENCY 73
571 ABORTION SPONTANEOUS 72
572 ALTERED STATE OF CONSCIOUSNESS 72
573 MOUTH SWELLING 72
574 RASH GENERALISED 72
575 DEATH NEONATAL 71
576 HYPOCHOLESTEROLAEMIA 71
577 OSTEOPENIA 71
578 CLOSTRIDIUM DIFFICILE INFECTION 70
579 DIVERTICULITIS 70
580 DYSTONIA 70
581 HALLUCINATION, VISUAL 70
582 INTERSTITIAL LUNG DISEASE 70
583 LYMPHOCYTE COUNT DECREASED 70
584 MANIA 70
585 PSYCHOTIC DISORDER 70
586 CEREBRAL HAEMORRHAGE 69
587 HYPOACUSIS 69
588 INTESTINAL OBSTRUCTION 69
589 LACTIC ACIDOSIS 69
590 SPUTUM DISCOLOURED 69
591 STAPHYLOCOCCAL INFECTION 69
592 QUALITY OF LIFE DECREASED 68
593 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 67
594 BLOOD GLUCOSE DECREASED 67
595 EOSINOPHIL COUNT INCREASED 67
596 EXPIRED PRODUCT ADMINISTERED 67
597 PSYCHOMOTOR HYPERACTIVITY 67
598 SKIN DISORDER 67
599 TRANSFUSION 67
600 CANDIDA INFECTION 66
601 CHOKING 66
602 DYSSTASIA 66
603 FEEDING DISORDER 66
604 SKIN IRRITATION 66
605 UPPER-AIRWAY COUGH SYNDROME 66
606 ABNORMAL DREAMS 65
607 MULTIPLE ALLERGIES 65
608 MULTIPLE SCLEROSIS RELAPSE 65
609 NEUTROPHIL COUNT DECREASED 65
610 ORTHOSTATIC HYPOTENSION 65
611 PARANOIA 65
612 ACUTE MYOCARDIAL INFARCTION 64
613 BRONCHIECTASIS 64
614 BRONCHOSPASM 64
615 CYSTIC FIBROSIS 64
616 DERMATITIS 64
617 HEREDITARY ANGIOEDEMA 64
618 MULTIPLE ORGAN DYSFUNCTION SYNDROME 64
619 SPINAL DISORDER 64
620 SURGERY 64
621 DEVICE MALFUNCTION 63
622 ENCEPHALOPATHY 63
623 HEAD DISCOMFORT 63
624 LUNG NEOPLASM MALIGNANT 63
625 NONINFECTIVE GINGIVITIS 63
626 ORAL HERPES 63
627 ANGIOPATHY 62
628 CHOLESTASIS 62
629 GOUT 62
630 LIMB INJURY 62
631 POST-TRAUMATIC STRESS DISORDER 62
632 DECREASED IMMUNE RESPONSIVENESS 61
633 EMPHYSEMA 61
634 EYE INJURY 61
635 HEPATIC STEATOSIS 61
636 INCREASED APPETITE 61
637 LABYRINTHITIS 61
638 NEUTROPHIL COUNT INCREASED 61
639 NODULE 61
640 SPINAL FUSION SURGERY 61
641 SUSPECTED OFF LABEL USE 61
642 THERAPEUTIC RESPONSE UNEXPECTED 61
643 BLOOD SODIUM DECREASED 60
644 FEAR 60
645 KIDNEY INFECTION 60
646 NERVOUS SYSTEM DISORDER 60
647 NEURALGIA 60
648 ACUTE RESPIRATORY DISTRESS SYNDROME 59
649 BLOOD PRESSURE DIASTOLIC DECREASED 59
650 HYPOPHAGIA 59
651 OSTEITIS 59
652 PRODUCT AVAILABILITY ISSUE 59
653 SLUGGISHNESS 59
654 AMYLOID ARTHROPATHY 58
655 BLOOD BILIRUBIN INCREASED 58
656 ECONOMIC PROBLEM 58
657 GENERALISED TONIC-CLONIC SEIZURE 58
658 HAEMATURIA 58
659 INJECTION SITE RASH 58
660 MUSCULOSKELETAL CHEST PAIN 58
661 SINUS TACHYCARDIA 58
662 SKIN ULCER 58
663 THERAPY PARTIAL RESPONDER 58
664 COVID-19 PNEUMONIA 57
665 EXTRA DOSE ADMINISTERED 57
666 FAECES DISCOLOURED 57
667 HYPERTHERMIA 57
668 MAST CELL ACTIVATION SYNDROME 57
669 MENTAL STATUS CHANGES 57
670 PETECHIAE 57
671 PRODUCT STORAGE ERROR 57
672 DERMATITIS CONTACT 56
673 GASTRIC DISORDER 56
674 HEART RATE IRREGULAR 56
675 INTERNATIONAL NORMALISED RATIO INCREASED 56
676 LOOSE TOOTH 56
677 PLASMA CELL MYELOMA 56
678 RHINITIS ALLERGIC 56
679 THIRST 56
680 TRANSAMINASES INCREASED 56
681 UROSEPSIS 56
682 ASPIRATION 55
683 BLOOD TEST ABNORMAL 55
684 DRUG DOSE OMISSION BY DEVICE 55
685 EMOTIONAL DISORDER 55
686 HAEMATOCRIT DECREASED 55
687 INFUSION SITE PAIN 55
688 OSTEONECROSIS 55
689 SKIN INFECTION 55
690 SOPOR 55
691 GASTROENTERITIS 54
692 HEPATOTOXICITY 54
693 HIATUS HERNIA 54
694 MUSCULOSKELETAL DISCOMFORT 54
695 NEPHROGENIC ANAEMIA 54
696 PULMONARY MASS 54
697 BACTERIAL INFECTION 53
698 BLOOD MAGNESIUM DECREASED 53
699 HAEMORRHOIDS 53
700 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 53
701 NEEDLE ISSUE 53
702 RESPIRATORY RATE INCREASED 53
703 TENDONITIS 53
704 CYANOSIS 52
705 DEAFNESS 52
706 HYPOTHERMIA 52
707 INJECTION SITE HAEMORRHAGE 52
708 REBOUND EFFECT 52
709 SKIN FISSURES 52
710 APATHY 51
711 BLOOD POTASSIUM INCREASED 51
712 BODY TEMPERATURE DECREASED 51
713 CONVULSION 51
714 HYPERTRANSAMINASAEMIA 51
715 HYPERVENTILATION 51
716 IMPAIRED WORK ABILITY 51
717 INTERVERTEBRAL DISC PROTRUSION 51
718 METABOLIC ACIDOSIS 51
719 PAPULE 51
720 PERIPHERAL COLDNESS 51
721 PNEUMONIA ASPIRATION 51
722 RIB FRACTURE 51
723 TENDON DISORDER 51
724 THINKING ABNORMAL 51
725 BLOOD CREATINE PHOSPHOKINASE INCREASED 50
726 CHRONIC FATIGUE SYNDROME 50
727 FOOT FRACTURE 50
728 HEPATIC FAILURE 50
729 TOXIC SKIN ERUPTION 50
730 FEELING JITTERY 49
731 FULL BLOOD COUNT DECREASED 49
732 GASTROINTESTINAL PAIN 49
733 HALLUCINATIONS, MIXED 49
734 MONOCYTE COUNT INCREASED 49
735 POISONING DELIBERATE 49
736 RHINOVIRUS INFECTION 49
737 SENSORY DISTURBANCE 49
738 TOOTH ABSCESS 49
739 BONE DISORDER 48
740 DEMYELINATION 48
741 GINGIVAL BLEEDING 48
742 LEUKOCYTOSIS 48
743 MATERNAL EXPOSURE DURING BREAST FEEDING 48
744 RESTRICTIVE PULMONARY DISEASE 48
745 BLOOD PRESSURE DIASTOLIC INCREASED 47
746 CARDIOVASCULAR DISORDER 47
747 CARPAL TUNNEL SYNDROME 47
748 COLD SWEAT 47
749 DELUSION 47
750 MIOSIS 47
751 OROPHARYNGEAL DISCOMFORT 47
752 RALES 47
753 REBOUND ACID HYPERSECRETION 47
754 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 47
755 RESPIRATORY ARREST 47
756 SEROTONIN SYNDROME 47
757 SYMPTOM RECURRENCE 47
758 EJECTION FRACTION DECREASED 46
759 HIP FRACTURE 46
760 INFUSION SITE ERYTHEMA 46
761 PRODUCT PRESCRIBING ERROR 46
762 RESPIRATORY SYNCYTIAL VIRUS INFECTION 46
763 SARS-COV-2 TEST POSITIVE 46
764 SCAB 46
765 SOMNAMBULISM 46
766 TACHYPNOEA 46
767 ATRIAL SEPTAL DEFECT 45
768 DECREASED ACTIVITY 45
769 HAEMATEMESIS 45
770 HEMIPARESIS 45
771 NEOPLASM MALIGNANT 45
772 PEMPHIGOID 45
773 PURPURA 45
774 ACCIDENT 44
775 GINGIVAL PAIN 44
776 GLOMERULAR FILTRATION RATE DECREASED 44
777 HYPOTONIA 44
778 INSURANCE ISSUE 44
779 INTERVERTEBRAL DISCITIS 44
780 LOCALISED INFECTION 44
781 PLATELET COUNT INCREASED 44
782 PROCTALGIA 44
783 SWELLING OF EYELID 44
784 ANGINA PECTORIS 43
785 ATTENTION DEFICIT HYPERACTIVITY DISORDER 43
786 BONE LOSS 43
787 EAR DISCOMFORT 43
788 ERECTILE DYSFUNCTION 43
789 PERICARDIAL EFFUSION 43
790 POOR VENOUS ACCESS 43
791 POST PROCEDURAL COMPLICATION 43
792 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 43
793 PULMONARY HYPERTENSION 43
794 SCHIZOPHRENIA 43
795 TENDERNESS 43
796 FIXED ERUPTION 42
797 GYNAECOMASTIA 42
798 HEPATIC CYTOLYSIS 42
799 LYMPHOPENIA 42
800 MASS 42
801 MENTAL IMPAIRMENT 42
802 PREMATURE BABY 42
803 PULMONARY FUNCTION TEST DECREASED 42
804 RENAL FAILURE ACUTE 42
805 SKIN HAEMORRHAGE 42
806 DEVICE RELATED INFECTION 41
807 DIABETIC KETOACIDOSIS 41
808 DRUG LEVEL INCREASED 41
809 EATING DISORDER 41
810 HAIR COLOUR CHANGES 41
811 NEOPLASM PROGRESSION 41
812 NEUTROPENIC SEPSIS 41
813 RIGHT VENTRICULAR FAILURE 41
814 APHONIA 40
815 BLOOD PRESSURE SYSTOLIC DECREASED 40
816 DIABETES MELLITUS INADEQUATE CONTROL 40
817 GLYCOSYLATED HAEMOGLOBIN INCREASED 40
818 OBSESSIVE-COMPULSIVE DISORDER 40
819 SEDATION COMPLICATION 40
820 VITAMIN B12 DECREASED 40
821 CUTANEOUS VASCULITIS 39
822 EXERCISE TOLERANCE DECREASED 39
823 GASTRIC ULCER 39
824 GLAUCOMA 39
825 PRODUCT USE COMPLAINT 39
826 PULMONARY CONGESTION 39
827 SINUS BRADYCARDIA 39
828 VAGINAL HAEMORRHAGE 39
829 VICTIM OF CHEMICAL SUBMISSION 39
830 WOUND SECRETION 39
831 ACUTE HEPATIC FAILURE 38
832 ATAXIA 38
833 CHOLECYSTITIS 38
834 COAGULOPATHY 38
835 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 38
836 FOOD POISONING 38
837 HYPERPARATHYROIDISM SECONDARY 38
838 INFUSION SITE SWELLING 38
839 LOCAL SWELLING 38
840 ORAL DISCOMFORT 38
841 PHARYNGITIS STREPTOCOCCAL 38
842 SCAR 38
843 THROAT CLEARING 38
844 TOOTH LOSS 38
845 UPPER LIMB FRACTURE 38
846 VENTRICULAR EXTRASYSTOLES 38
847 AGRANULOCYTOSIS 37
848 BLOOD URINE PRESENT 37
849 DEVICE LEAKAGE 37
850 DRUG EFFECT INCOMPLETE 37
851 GALLBLADDER DISORDER 37
852 HEPATITIS ACUTE 37
853 INTERVERTEBRAL DISC DEGENERATION 37
854 MICTURITION URGENCY 37
855 OCULAR DISCOMFORT 37
856 PRODUCT DISPENSING ERROR 37
857 PRODUCT DISTRIBUTION ISSUE 37
858 RENAL PAIN 37
859 SMALL FOR DATES BABY 37
860 SPINAL FRACTURE 37
861 SPINAL OSTEOARTHRITIS 37
862 VISUAL ACUITY REDUCED 37
863 APPENDICITIS 36
864 BREAST MASS 36
865 CORONARY ARTERY DISEASE 36
866 DERMATITIS BULLOUS 36
867 DIZZINESS POSTURAL 36
868 DRUG EFFECT DECREASED 36
869 ELECTRIC SHOCK 36
870 EXPOSURE VIA SKIN CONTACT 36
871 GESTATIONAL DIABETES 36
872 HEPATIC FUNCTION ABNORMAL 36
873 HERNIA 36
874 HYPOALBUMINAEMIA 36
875 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 36
876 INCREASED TENDENCY TO BRUISE 36
877 INITIAL INSOMNIA 36
878 IRON DEFICIENCY ANAEMIA 36
879 PRODUCT PRESCRIBING ISSUE 36
880 PULMONARY ARTERIAL HYPERTENSION 36
881 RADIATION INFLAMMATION 36
882 TOOTH INFECTION 36
883 BLOOD IRON DECREASED 35
884 BRADYPHRENIA 35
885 DROOLING 35
886 EYELID OEDEMA 35
887 FLUID OVERLOAD 35
888 GASTROINTESTINAL HYPOMOTILITY 35
889 HEPATOMEGALY 35
890 MUSCLE TIGHTNESS 35
891 PRODUCT TASTE ABNORMAL 35
892 RESPIRATORY DEPRESSION 35
893 SENSITIVITY TO WEATHER CHANGE 35
894 SKIN LACERATION 35
895 TONSILLITIS 35
896 URTICARIA CHRONIC 35
897 AFFECTIVE DISORDER 34
898 BRUXISM 34
899 CHOLECYSTITIS ACUTE 34
900 ERYTHEMA MULTIFORME 34
901 FRUSTRATION TOLERANCE DECREASED 34
902 INFUSION SITE EXTRAVASATION 34
903 ORAL PRURITUS 34
904 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 34
905 SINUS HEADACHE 34
906 SMALL INTESTINAL OBSTRUCTION 34
907 SUBDURAL HAEMATOMA 34
908 SUPRAVENTRICULAR TACHYCARDIA 34
909 ABDOMINAL PAIN LOWER 33
910 AFFECT LABILITY 33
911 CARDIOMEGALY 33
912 CLOSTRIDIUM DIFFICILE COLITIS 33
913 DEFAECATION URGENCY 33
914 DEVICE DELIVERY SYSTEM ISSUE 33
915 FEELING OF DESPAIR 33
916 INJECTION SITE MASS 33
917 MUSCLE FATIGUE 33
918 TIC 33
919 UPPER GASTROINTESTINAL HAEMORRHAGE 33
920 VITAMIN B12 DEFICIENCY 33
921 ASCITES 32
922 BACTERAEMIA 32
923 BLOOD URIC ACID INCREASED 32
924 CEREBRAL DISORDER 32
925 COLITIS MICROSCOPIC 32
926 INJECTION SITE URTICARIA 32
927 JOINT NOISE 32
928 MOTOR DYSFUNCTION 32
929 PNEUMONIA BACTERIAL 32
930 TARDIVE DYSKINESIA 32
931 TERMINAL INSOMNIA 32
932 TOOTHACHE 32
933 WHITE BLOOD CELLS URINE POSITIVE 32
934 ARTHROPOD BITE 31
935 BRADYKINESIA 31
936 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 31
937 CARDIAC FLUTTER 31
938 CARDIOGENIC SHOCK 31
939 DRY THROAT 31
940 FEELING DRUNK 31
941 HEPATIC ENZYME 31
942 HYPERBILIRUBINAEMIA 31
943 LIBIDO DECREASED 31
944 MYOCARDITIS 31
945 SPLENOMEGALY 31
946 THERAPY CHANGE 31
947 ABSCESS 30
948 APHTHOUS ULCER 30
949 DECUBITUS ULCER 30
950 HOSPICE CARE 30
951 ISCHAEMIC STROKE 30
952 JOINT INJURY 30
953 LUNG INFECTION 30
954 NASAL DRYNESS 30
955 OSTEONECROSIS OF JAW 30
956 PARKINSONISM 30
957 SCREAMING 30
958 SKIN CANCER 30
959 ANKLE FRACTURE 29
960 ASPARTATE AMINOTRANSFERASE ABNORMAL 29
961 BRADYPNOEA 29
962 BRAIN OEDEMA 29
963 DEPRESSION SUICIDAL 29
964 GASTROINTESTINAL MOTILITY DISORDER 29
965 GENITAL PAIN 29
966 HYPERTHYROIDISM 29
967 MALNUTRITION 29
968 PERIORBITAL SWELLING 29
969 PNEUMOCYSTIS JIROVECII PNEUMONIA 29
970 RASH MORBILLIFORM 29
971 ROTATOR CUFF SYNDROME 29
972 SNORING 29
973 TOOTH DISORDER 29
974 VITAMIN B12 INCREASED 29
975 VITAMIN D DECREASED 29
976 VOCAL CORD DYSFUNCTION 29
977 WRIST FRACTURE 29
978 BASAL CELL CARCINOMA 28
979 BLOOD PRESSURE ABNORMAL 28
980 BONE MARROW FAILURE 28
981 BRONCHOPULMONARY ASPERGILLOSIS 28
982 EYE INFECTION 28
983 INJECTION SITE INDURATION 28
984 MYASTHENIA GRAVIS 28
985 NERVE COMPRESSION 28
986 PNEUMOTHORAX 28
987 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 28
988 RESPIRATORY ACIDOSIS 28
989 SENSORY LOSS 28
990 SYNOVIAL CYST 28
991 TORSADE DE POINTES 28
992 TRISMUS 28
993 WRONG TECHNIQUE IN DRUG USAGE PROCESS 28
994 ACIDOSIS 27
995 AMENORRHOEA 27
996 ANAL INCONTINENCE 27
997 BREATH SOUNDS ABNORMAL 27
998 BRONCHIAL DISORDER 27
999 DACTYLITIS 27